Novel approaches in treatment of pediatric anxiety
Open accessThe DOI matches its Crossref record; 65 of the 69 references it cites were found in a registry or an index; none of the 57 sources its claims cite is checked for support yet.
Abstract
Pediatric anxiety disorders have high prevalence rates andmorbidity and are associated with considerable functional impairment and distress. They may be predictors for the development of other psychiatric disorders and, without intervention, are more likely to persist into adulthood. While evidence-based pharmacological and behavioral interventions are currently available, there remains a sizable subset of youth who remain only partially treatment-responsive and therefore symptomatic following treatment. Novel methods of treatment, pharmacologic and non-pharmacologic, including acceptance and commitment therapy (ACT), attention bias modification (ABM), d-cycloserine (DCS) augmentation of cognitive behavioral treatment (CBT), and glutamatergic agents such as riluzole, are briefly introduced and discussed. © 2014 Faculty of 1000 Ltd.
Overview
CoChat Summary
TL;DR
This review argues that although CBT and SSRIs are effective first-line treatments for pediatric anxiety, up to 50% of youth still meet criteria after treatment, motivating novel approaches. It briefly reviews emerging pharmacologic and non-pharmacologic strategies, especially ACT, attention bias modification, d-cycloserine, and riluzole.
Key findings
- Pediatric anxiety disorders are common, with prevalence rates of 10% to 20%, and are linked to chronic impairment, comorbidity, and later anxiety or major depression if untreated.
- In a multisite study cited by the paper, response rates were 81% for sertraline + CBT, 60% for CBT monotherapy, 55% for sertraline monotherapy, and 24% for placebo.
- For attention bias modification (ABM), the paper reports:
- 2 sessions increased attention disengagement from threat in chronically anxious children (mean age 10 years),
- 4 sessions reduced clinician severity ratings in an RCT of children ages 8 to 14 years,
- and ABM plus daily CBT produced greater symptom reductions than CBT alone in youth ages 13 to 17 years in a residential setting.
- For riluzole in youth, a 12-week open-label study in 6 children/adolescents with treatment-resistant OCD found substantial symptom reduction in 4 of 6 participants, but a 12-week RCT in 60 youth found no significant difference versus placebo-augmented treatment.
- For d-cycloserine (DCS) in youth, the paper states that one published study in children with OCD ages 8 to 17 years found no significant differences versus CBT alone, though effect sizes on primary outcomes were d = 0.31–0.47.
Methods
- Narrative review of emerging treatments for pediatric anxiety disorders, with sections on non-pharmacologic and pharmacologic approaches.
- Draws on previously published studies in children and adolescents, including case studies, open-label trials, RCTs, and adult trials cited for mechanistic or translational support.
- Main analysis is descriptive synthesis of the literature rather than a new empirical dataset or meta-analysis.
Limitations
- The paper itself notes that empirical research specifically examining ACT for pediatric anxiety disorders is sparse, and that there is a dearth of evidence for ACT in this population.
- It also notes that the pediatric riluzole RCT may have been limited by sample characteristics and high rates of concomitant medications.
- Evident from the text: this is a brief review, so conclusions are based on a small and heterogeneous set of studies rather than pooled quantitative analysis.
Model-written summary. Check it against the paper before relying on it.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
0 Valid · 0 Not valid · 27 Not checked · 5 Own results and interpretations
A result the paper states — it cites no source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Still, a dearth of empirical research has specifically examined ACT for pediatric anxiety disorders.”
§ Novel approaches in treatment of pediatric anxiety > Non-pharmacological interventions > Acceptance and commitment therapy
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
In the paper
“In youth, only one published study has examined DCS as an adjunct to E/RP [61].”
§ Novel approaches in treatment of pediatric anxiety > Pharmacological interventions > D-cycloserine
What the sources say
- Not matchedcites [61]
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Not matched
In the paper
“In sum, glutamatergic activity at the NMDA receptor seems to be critically involved in the neural mechanisms of learning and memory [42].”
§ Novel approaches in treatment of pediatric anxiety > Pharmacological interventions > Cognitive enhancers
What the sources say
- Not matchedcites [42]
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
hedgedstates a possible cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Not matched
None of the sources cited for this claim could be matched to a paper in Crossref, so there is nothing to check it against.
In the paper
“In adult trials, DCS demonstrated augmenting effects in the treatment of specific phobia of heights, social phobia, panic disorder, and OCD [54-59].”
§ Novel approaches in treatment of pediatric anxiety > Pharmacological interventions > D-cycloserine
What the sources say
- Not matchedcites [54]
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
- Not matchedcites [55]
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
- Not matchedcites [56]
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
- Not matchedcites [57]
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
- Not matchedcites [58]
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
- Not matchedcites [59]
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
boostedstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Not matched
In the paper
“In a study of youth ages 13 to 17 years in a residential unit for severe anxiety, those who received ABM in addition to daily (weekday) CBT had significantly greater reductions in anxiety symptoms at post-treatment relative to those who received CBT alone [34].”
§ Novel approaches in treatment of pediatric anxiety > Non-pharmacological interventions > Attention bias modification
What the sources say
- Not matchedcites [34]
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
plainstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Not matched
14 more claims
Create a free account to see all 32 claims and every source verdict.
- Probably not a substantial claim. 5
- It may state two separate claims as one. 9
Citations
Cites
Acceptance and commitment therapy: model, processes and outcomes
Hayes, S. C., Luoma, J. B., Bond, F. W., Masuda, A., & Lillis, J. (2006) · Behaviour Research and Therapy · doi:10.1016/j.brat.2005.06.006 · Cited by 6,587 · cited 2×
“ACT seeks to increase psychological flexibility through cognitive defusion and acceptance [14].”
Background(1999) · Cited by 5,934
Threat-related attentional bias in anxious and nonanxious individuals: a meta-analytic study.
Bar-Haim, Y., Lamy, D., Pergamin, L., Bakermans-Kranenburg, M. J., & van IJzendoorn, M. H. (2007) · Psychological Bulletin · doi:10.1037/0033-2909.133.1.1 · Cited by 3,721
Attentional bias in emotional disorders
MacLeod, C., Mathews, A., & Tata, P. (1986) · Journal of Abnormal Psychology · doi:10.1037/0021-843x.95.1.15 · Cited by 3,152 · cited 1×
“Most frequently, a computerbased dot-probe task is used, and the difference in response times in the identification of a visual probe when paired with threatening or neutral stimuli is used as the attention bias index [27,28].”
MethodHasin, D. S., Stinson, F. S., Ogburn, E., & Grant, B. F. (2007) · Archives of General Psychiatry · doi:10.1001/archpsyc.64.7.830 · Cited by 2,908
AMPA Receptor Trafficking and Synaptic Plasticity
Malinow, R., & Malenka, R. C. (2002) · Annual Review of Neuroscience · doi:10.1146/annurev.neuro.25.112701.142758 · Cited by 2,588 · cited 1×
“NMDA receptors have an established role in the induction of many forms of neuroplasticity best seen in long-term potentiation (LTP) [37-41].”
BackgroundPine, D. S., Cohen, P., Gurley, D., Brook, J., & Ma, Y. (1998) · Archives of General Psychiatry · doi:10.1001/archpsyc.55.1.56 · Cited by 1,753 · cited 2×
“When left untreated, anxiety in childhood is a predictor for anxiety disorders and major depression later in life [7].”
BackgroundCognitive Behavioral Therapy, Sertraline, or a Combination in Childhood Anxiety
Walkup, J. T., Albano, A. M., Piacentini, J., Birmaher, B., Compton, S. N., Sherrill, J. T., Ginsburg, G. S., Rynn, M. A., McCracken, J., Waslick, B., et al. (2008) · New England Journal of Medicine · doi:10.1056/nejmoa0804633 · Cited by 1,442 · cited 1×
“Monotherapy and combination therapy (SSRIs + CBT) have been demonstrated to be efficacious in large comparative trials; one multisite study reported treatment response rates of 81% for sertraline + CBT combination therapy, 60% for CBT monotherapy, and 55% for sertraline monotherapy, relative to a 24% response rate for…”
MacLeod, C., Rutherford, E., Campbell, L., Ebsworthy, G., & Holker, L. (2002) · Journal of Abnormal Psychology · doi:10.1037/0021-843x.111.1.107 · Cited by 1,334 · cited 1×
“Attention biases toward threat-related stimuli are postulated to contribute to the etiology and maintenance of anxiety disorders [25,26].”
BackgroundRegulation of distinct AMPA receptor phosphorylation sites during bidirectional synaptic plasticity
Lee, H.-K., Barbarosie, M., Kameyama, K., Bear, M. F., & Huganir, R. L. (2000) · Nature · doi:10.1038/35016089 · Cited by 1,116 · cited 1×
“NMDA receptors have an established role in the induction of many forms of neuroplasticity best seen in long-term potentiation (LTP) [37-41].”
BackgroundRessler, K. J., Rothbaum, B. O., Tannenbaum, L., Anderson, P., Graap, K., Zimand, E., Hodges, L., & Davis, M. (2004) · Archives of General Psychiatry · doi:10.1001/archpsyc.61.11.1136 · Cited by 1,063 · cited 14×
“Amongst children withOCD (ages 8 to 17 years), no significant differences were found between the DCS-augmented E/RP group and the CBTalone group; however, the DCS-augmented E/RP group showed small tomoderate treatment effects (d = 0.31-0.47) on primary OCD outcomemeasures.”
BackgroundInfluentialVolkmar, F., Siegel, M., Woodbury-Smith, M., King, B., McCracken, J., & State, M. (2014) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1016/j.jaac.2013.10.013 · Cited by 848
Anxiety Disorders During Childhood and Adolescence: Origins and Treatment
Rapee, R. M., Schniering, C. A., & Hudson, J. L. (2009) · Annual Review of Clinical Psychology · doi:10.1146/annurev.clinpsy.032408.153628 · Cited by 821 · cited 2×
“While CBT and SSRIs are considered first-line treatment for youth with anxiety, up to 50% continue to meet criteria for anxiety disorder after treatment [1,2,11].”
BackgroundWalker, D. L., Ressler, K. J., Lu, K.-T., & Davis, M. (2002) · The Journal of Neuroscience · doi:10.1523/jneurosci.22-06-02343.2002 · Cited by 815 · cited 1×
“DCS is an NMDA partial agonist that has been shown to enhance fear extinction learning in both animals and humans [51-53].”
BackgroundRegulation of AMPA receptors during synaptic plasticity
Song, I., & Huganir, R. L. (2002) · Trends in Neurosciences · doi:10.1016/s0166-2236(02)02270-1 · Cited by 777 · cited 1×
“NMDA receptors have an established role in the induction of many forms of neuroplasticity best seen in long-term potentiation (LTP) [37-41].”
BackgroundComorbidity of anxiety and depression in children and adolescents
Brady, E. U., & Kendall, P. C. (1992) · Psychological Bulletin · doi:10.1037/0033-2909.111.2.244 · Cited by 748 · cited 1×
“Pediatric anxiety disorders have high levels of comorbidity with other anxiety disorders, depression, and disruptive behavior disorders and are associated with significant psychosocial impairment as well as increased likelihood of substance abuse and suicidal behavior [3-8].”
BackgroundWhat do childhood anxiety disorders predict?
Bittner, A., Egger, H. L., Erkanli, A., Jane Costello, E., Foley, D. L., & Angold, A. (2007) · Journal of Child Psychology and Psychiatry · doi:10.1111/j.1469-7610.2007.01812.x · Cited by 733 · cited 2×
“Pediatric anxiety disorders have high levels of comorbidity with other anxiety disorders, depression, and disruptive behavior disorders and are associated with significant psychosocial impairment as well as increased likelihood of substance abuse and suicidal behavior [3-8].”
BackgroundBurke, C. A. (2010) · Journal of Child and Family Studies · doi:10.1007/s10826-009-9282-x · Cited by 730 · cited 1×
“Studies have also demonstrated that therapy based on mindfulness (which is a core component of ACT) is effective in reducing anxiety symptoms in children and adolescents [21,22].”
BackgroundForman, E. M., Herbert, J. D., Moitra, E., Yeomans, P. D., & Geller, P. A. (2007) · Behavior Modification · doi:10.1177/0145445507302202 · Cited by 687 · cited 1×
“Favorable results in adult trials [12,13] have spurred discussion regarding the application and utility of ACT for the treatment of pediatric anxiety disorders.”
BackgroundEvidence-based psychosocial treatments for phobic and anxiety disorders in children and adolescents
Silverman, W. K., Pina, A. A., & Viswesvaran, C. (2008) · Journal of Clinical Child & Adolescent Psychology · doi:10.1080/15374410701817907 · Cited by 660 · cited 2×
“While CBT and SSRIs are considered first-line treatment for youth with anxiety, up to 50% continue to meet criteria for anxiety disorder after treatment [1,2,11].”
BackgroundCOMPTON, S. N., MARCH, J. S., BRENT, D., ALBANO, A. M., WEERSING, V. R., & CURRY, J. (2004) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1097/01.chi.0000127589.57468.bf · Cited by 616 · cited 1×
“While CBT and SSRIs are considered first-line treatment for youth with anxiety, up to 50% continue to meet criteria for anxiety disorder after treatment [1,2,11].”
BackgroundAugmentation of Exposure Therapy With D-Cycloserine for Social Anxiety Disorder
Hofmann, S. G., Meuret, A. E., Smits, J. A. J., Simon, N. M., Pollack, M. H., Eisenmenger, K., Shiekh, M., & Otto, M. W. (2006) · Archives of General Psychiatry · doi:10.1001/archpsyc.63.3.298 · Cited by 560 · cited 13×
“Amongst children withOCD (ages 8 to 17 years), no significant differences were found between the DCS-augmented E/RP group and the CBTalone group; however, the DCS-augmented E/RP group showed small tomoderate treatment effects (d = 0.31-0.47) on primary OCD outcomemeasures.”
BackgroundInfluentialConnolly, S. D., & Bernstein, G. A. (2007) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1097/01.chi.0000246070.23695.06 · Cited by 548 · cited 1×
“CBT and selective serotonin reuptake inhibitors (SSRIs) have emerged as the most empirically robust treatment modalities for pediatric anxiety disorders [9].”
BackgroundA meta-analysis of D-cycloserine and the facilitation of fear extinction and exposure therapy
Norberg, M. M., Krystal, J. H., & Tolin, D. F. (2008) · Biological Psychiatry · doi:10.1016/j.biopsych.2008.01.012 · Cited by 510
Effects of D-cycloserine on extinction of conditioned freezing.
Ledgerwood, L., Richardson, R., & Cranney, J. (2003) · Behavioral Neuroscience · doi:10.1037/0735-7044.117.2.341 · Cited by 388 · cited 1×
“DCS is an NMDA partial agonist that has been shown to enhance fear extinction learning in both animals and humans [51-53].”
BackgroundD-Cycloserine Augmented Exposure Therapy for Obsessive-Compulsive Disorder
Kushner, M. G., Kim, S. W., Donahue, C., Thuras, P., Adson, D., Kotlyar, M., McCabe, J., Peterson, J., & Foa, E. B. (2007) · Biological Psychiatry · doi:10.1016/j.biopsych.2006.12.020 · Cited by 384 · cited 1×
“Among the eight human studies using DCS as an adjunct to psychotherapy, there have been few to no adverse events [57,59,61,62].”
BackgroundFamily-Based Cognitive-Behavioral Therapy for Pediatric Obsessive-Compulsive Disorder
STORCH, E. A., GEFFKEN, G. R., MERLO, L. J., MANN, G., DUKE, D., MUNSON, M., ADKINS, J., GRABILL, K. M., MURPHY, T. K., & GOODMAN, W. K. (2007) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1097/chi.0b013e31803062e7 · Cited by 382 · cited 14×
“Amongst children withOCD (ages 8 to 17 years), no significant differences were found between the DCS-augmented E/RP group and the CBTalone group; however, the DCS-augmented E/RP group showed small tomoderate treatment effects (d = 0.31-0.47) on primary OCD outcomemeasures.”
MethodInfluentialAugmentation of Behavior Therapy With d -Cycloserine for Obsessive-Compulsive Disorder
Wilhelm, S., Buhlmann, U., Tolin, D. F., Meunier, S. A., Pearlson, G. D., Reese, H. E., Cannistraro, P., Jenike, M. A., & Rauch, S. L. (2008) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2007.07050776 · Cited by 358 · cited 14×
“Amongst children withOCD (ages 8 to 17 years), no significant differences were found between the DCS-augmented E/RP group and the CBTalone group; however, the DCS-augmented E/RP group showed small tomoderate treatment effects (d = 0.31-0.47) on primary OCD outcomemeasures.”
BackgroundInfluentialGlutamatergic Dysfunction in OCD
Chakrabarty, K., Bhattacharyya, S., Christopher, R., & Khanna, S. (2005) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300733 · Cited by 344 · cited 1×
“Central glutamatergic systems have been implicated in the pathophysiology of various anxiety disorders [36].”
BackgroundTreating Anxiety With Mindfulness: An Open Trial of Mindfulness Training for Anxious Children
Semple, R. J., Reid, E. F. G., & Miller, L. (2005) · Journal of Cognitive Psychotherapy · doi:10.1891/jcop.2005.19.4.379 · Cited by 326 · cited 1×
“Studies have also demonstrated that therapy based on mindfulness (which is a core component of ACT) is effective in reducing anxiety symptoms in children and adolescents [21,22].”
BackgroundGuastella, A. J., Richardson, R., Lovibond, P. F., Rapee, R. M., Gaston, J. E., Mitchell, P., & Dadds, M. R. (2008) · Biological Psychiatry · doi:10.1016/j.biopsych.2007.11.011 · Cited by 326
Riluzole augmentation in treatment-resistant obsessive-compulsive disorder: An open-label trial
Coric, V., Taskiran, S., Pittenger, C., Wasylink, S., Mathalon, D. H., Valentine, G., Saksa, J., Wu, Y.-T., Gueorguieva, R., Sanacora, G., et al. (2005) · Biological Psychiatry · doi:10.1016/j.biopsych.2005.04.043 · Cited by 314 · cited 1×
“Several open-label trials in adults examining riluzole as monotherapy or an adjunct therapy have resulted in significant reductions in anxiety symptoms after treatment [44,45].”
BackgroundAcceptance and Commitment Therapy for Generalized Social Anxiety Disorder: A Pilot Study
Dalrymple, K. L., & Herbert, J. D. (2007) · Behavior Modification · doi:10.1177/0145445507302037 · Cited by 312 · cited 1×
“Favorable results in adult trials [12,13] have spurred discussion regarding the application and utility of ACT for the treatment of pediatric anxiety disorders.”
BackgroundPsychosocial Impairment Associated With Anxiety in Children
Strauss, C. C., Frame, C. L., & Forehand, R. (1987) · Journal of Clinical Child Psychology · doi:10.1207/s15374424jccp1603_8 · Cited by 281 · cited 1×
“Pediatric anxiety disorders have high levels of comorbidity with other anxiety disorders, depression, and disruptive behavior disorders and are associated with significant psychosocial impairment as well as increased likelihood of substance abuse and suicidal behavior [3-8].”
BackgroundResearch Review: A neuroscience framework for pediatric anxiety disorders
Pine, D. S. (2007) · Journal of Child Psychology and Psychiatry · doi:10.1111/j.1469-7610.2007.01751.x · Cited by 276 · cited 1×
“Most frequently, a computerbased dot-probe task is used, and the difference in response times in the identification of a visual probe when paired with threatening or neutral stimuli is used as the attention bias index [27,28].”
MethodEfficacy of D-Cycloserine for Enhancing Response to Cognitive-Behavior Therapy for Panic Disorder
Otto, M. W., Tolin, D. F., Simon, N. M., Pearlson, G. D., Basden, S., Meunier, S. A., Hofmann, S. G., Eisenmenger, K., Krystal, J. H., & Pollack, M. H. (2010) · Biological Psychiatry · doi:10.1016/j.biopsych.2009.07.036 · Cited by 251
BODEN, J. M., FERGUSSON, D. M., & JOHN HORWOOD, L. (2007) · Psychological Medicine · doi:10.1017/s0033291706009147 · Cited by 249 · cited 1×
“Pediatric anxiety disorders have high levels of comorbidity with other anxiety disorders, depression, and disruptive behavior disorders and are associated with significant psychosocial impairment as well as increased likelihood of substance abuse and suicidal behavior [3-8].”
BackgroundRegulation of Synaptic Strength by Protein Phosphatase 1
Morishita, W., Connor, J. H., Xia, H., Quinlan, E. M., Shenolikar, S., & Malenka, R. C. (2001) · Neuron · doi:10.1016/s0896-6273(01)00554-2 · Cited by 227
Davis, M., & Myers, K. M. (2002) · Biological Psychiatry · doi:10.1016/s0006-3223(02)01507-x · Cited by 200 · cited 1×
“In sum, glutamatergic activity at the NMDA receptor seems to be critically involved in the neural mechanisms of learning and memory [42].”
BackgroundGrant, P., Lougee, L., Hirschtritt, M., & Swedo, S. E. (2007) · Journal of Child and Adolescent Psychopharmacology · doi:10.1089/cap.2007.0021 · Cited by 197 · cited 13×
“Amongst children withOCD (ages 8 to 17 years), no significant differences were found between the DCS-augmented E/RP group and the CBTalone group; however, the DCS-augmented E/RP group showed small tomoderate treatment effects (d = 0.31-0.47) on primary OCD outcomemeasures.”
BackgroundInfluentialVasey, M. W., El-Hag, N. F., & Daleiden, E. L. (1996) · Child Development · doi:10.1111/j.1467-8624.1996.tb01789.x · Cited by 194 · cited 1×
“Faster response times when the threatening stimuli are presented indicate an attention bias toward threat; these findings have been consistently demonstrated in both adults and children with anxiety [25,29,30].”
ResultStorch, E. A., Murphy, T. K., Goodman, W. K., Geffken, G. R., Lewin, A. B., Henin, A., Micco, J. A., Sprich, S., Wilhelm, S., Bengtson, M., et al. (2010) · Biological Psychiatry · doi:10.1016/j.biopsych.2010.07.015 · Cited by 193 · cited 9×
“Amongst children withOCD (ages 8 to 17 years), no significant differences were found between the DCS-augmented E/RP group and the CBTalone group; however, the DCS-augmented E/RP group showed small tomoderate treatment effects (d = 0.31-0.47) on primary OCD outcomemeasures.”
BackgroundInfluentialSelf-citationTelzer, E. H., Mogg, K., Bradley, B. P., Mai, X., Ernst, M., Pine, D. S., & Monk, C. S. (2008) · Biological Psychology · doi:10.1016/j.biopsycho.2008.05.004 · Cited by 187 · cited 1×
“Faster response times when the threatening stimuli are presented indicate an attention bias toward threat; these findings have been consistently demonstrated in both adults and children with anxiety [25,29,30].”
ResultCoyne, L. W., McHugh, L., & Martinez, E. R. (2011) · Child and Adolescent Psychiatric Clinics of North America · doi:10.1016/j.chc.2011.01.010 · Cited by 168 · cited 1×
“Rather than direct symptom reduction, the goal of treatment is to engage in behaviors that will facilitate living a life that reflects the individual’s values, and as a side effect of this goal, symptoms associated with psychiatric disorders may subside [17].”
BackgroundHeffner, M., Sperry, J., Eifert, G. H., & Detweiler, M. (2002) · Cognitive and Behavioral Practice · doi:10.1016/s1077-7229(02)80053-0 · Cited by 162 · cited 1×
“However, several reports note the successful application of ACT in the treatment of various pediatric populations [18-20].”
BackgroundTraining anxious children to disengage attention from threat: a randomized controlled trial
Bar‐Haim, Y., Morag, I., & Glickman, S. (2011) · Journal of Child Psychology and Psychiatry · doi:10.1111/j.1469-7610.2011.02368.x · Cited by 158 · cited 2×
“[31] RCT; n = 34; ages: 8-14 years; 2 sessions Reduction in threat bias in ABM group Separation anxiety, social phobia, specific phobia, and generalized anxiety disorder ABM Eldar et al.”
BackgroundLearning mechanisms: the case for CaM-KII
Lisman, J., Malenka, R. C., Nicoll, R. A., & Malinow, R. (1997) · Science · doi:10.1126/science.276.5321.2001 · Cited by 147 · cited 1×
“NMDA receptors have an established role in the induction of many forms of neuroplasticity best seen in long-term potentiation (LTP) [37-41].”
BackgroundVasey, M. W., El-Hag, N. F., & Daleiden, E. L. (1996) · Child Development · doi:10.2307/1131886 · Cited by 146
Open-Label Trial of Riluzole in Generalized Anxiety Disorder
Mathew, S. J., Amiel, J. M., Coplan, J. D., Fitterling, H. A., Sackeim, H. A., & Gorman, J. M. (2005) · American Journal of Psychiatry · doi:10.1176/appi.ajp.162.12.2379 · Cited by 134 · cited 1×
“Several open-label trials in adults examining riluzole as monotherapy or an adjunct therapy have resulted in significant reductions in anxiety symptoms after treatment [44,45].”
BackgroundBehavior Therapy for Obsessive Compulsive Disorder
Dar, R., & Greist, J. H. (1992) · Psychiatric Clinics of North America · doi:10.1016/s0193-953x(18)30216-8 · Cited by 120 · cited 1×
“substantial decrease in anxiety by the end of the exposure) [48].”
BackgroundShechner, T., Rimon-Chakir, A., Britton, J. C., Lotan, D., Apter, A., Bliese, P. D., Pine, D. S., & Bar-Haim, Y. (2014) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1016/j.jaac.2013.09.016 · Cited by 118 · cited 1×
“Whereas both ABM and placebo groups showed significantly greater reductions in clinical ratings relative to the CBT-only group, only the active ABM group had significant reductions in parent- and self-rated anxiety measures [35].”
ResultNeed for speed: Evaluating slopes of OCD recovery in behavior therapy enhanced with d-cycloserine
Chasson, G. S., Buhlmann, U., Tolin, D. F., Rao, S. R., Reese, H. E., Rowley, T., Welsh, K. S., & Wilhelm, S. (2010) · Behaviour Research and Therapy · doi:10.1016/j.brat.2010.03.007 · Cited by 106
Guastella, A. J., Lovibond, P. F., Dadds, M. R., Mitchell, P., & Richardson, R. (2007) · Behaviour Research and Therapy · doi:10.1016/j.brat.2006.07.005 · Cited by 106 · cited 13×
“Amongst children withOCD (ages 8 to 17 years), no significant differences were found between the DCS-augmented E/RP group and the CBTalone group; however, the DCS-augmented E/RP group showed small tomoderate treatment effects (d = 0.31-0.47) on primary OCD outcomemeasures.”
BackgroundInfluentialRiluzole in psychiatry: a systematic review of the literature
Zarate, C. A., & Manji, H. K. (2008) · Expert Opinion on Drug Metabolism & Toxicology · doi:10.1517/17425255.4.9.1223 · Cited by 103 · cited 1×
“Riluzole, an anti-glutamatergic agent, has been examined for its anxiolytic effects on anxiety disorders [43].”
BackgroundWicksell, R. K., Dahl, J., Magnusson, B., & Olsson, G. L. (2005) · Cognitive and Behavioral Practice · doi:10.1016/s1077-7229(05)80069-0 · Cited by 95
FRANCES, R. J. (2008) · Yearbook of Psychiatry and Applied Mental Health · doi:10.1016/s0084-3970(08)70671-6 · Cited by 89
Grant, P. J., Joseph, L. A., Farmer, C., Luckenbaugh, D. A., Lougee, L., Zarate, C. A., & Swedo, S. E. (2013) · Neuropsychopharmacology · doi:10.1038/npp.2013.343 · Cited by 83 · cited 1×
“sample characteristics and high rates of concomitant medications) [47]”
BackgroundIntegrating Acceptance and Mindfulness into Treatments for Child and Adolescent Anxiety Disorders
Greco, L. A., Blackledge, J. T., Coyne, L. W., & Ehrenreich, J. T. (2007) · Springer eBooks · doi:10.1007/0-387-25989-9_12 · Cited by 65
Brown, F. J., & Hooper, S. (2009) · Journal of Intellectual Disabilities · doi:10.1177/1744629509346173 · Cited by 64 · cited 3×
“In a case study, the anxiety and obsessive thoughts of an 18-year-old female with moderate mental retardation were treated with a 17-session ACT protocol that was modified for her developmental level [23].”
BackgroundMethodInfluentialRiemann, B. C., Kuckertz, J. M., Rozenman, M., Weersing, V. R., & Amir, N. (2013) · Depression and Anxiety · doi:10.1002/da.22127 · Cited by 58 · cited 1×
“greater reductions in anxiety symptoms at post-treatment relative to those who received CBT alone [34].”
MethodBechor, M., Pettit, J. W., Silverman, W. K., Bar-Haim, Y., Abend, R., Pine, D. S., Vasey, M. W., & Jaccard, J. (2014) · Journal of Anxiety Disorders · doi:10.1016/j.janxdis.2013.09.001 · Cited by 50 · cited 2×
“A case series reported downward trends of anxiety ratings from pre- to post-treatment following 8 sessions of ABM with anxious children who were deemed non-responders to a 12- to 14-week trial of CBT [33].”
BackgroundSwain, J., Hancock, K., Dixon, A., Koo, S., & Bowman, J. (2013) · Trials · doi:10.1186/1745-6215-14-140 · Cited by 37 · cited 1×
“Currently, a randomized controlled study is under way to examine the efficacy of ACT relative to CBT andwait-list control groups delivered via group therapy in the treatment of pediatric anxiety disorders [24].”
BackgroundAcceptance and commitment therapy for generalized social anxiety disorder
Dalrymple, K. L., & Herbert, J. D. (2005) · iDEA - Drexel University Institutional Repository · doi:10.17918/etd-612 · Cited by 6
Attention Bias Modification Treatment for Pediatric Anxiety Disorders: A Randomized Controlled Trial
Ballenger, J. C. (2012) · Yearbook of Psychiatry and Applied Mental Health · doi:10.1016/j.ypsy.2012.06.009 · Cited by 5
Cited by
Navigating the complex behavioral landscape of children in foster care and adopted families
Choi, A., & Kadam, S. J. (2025) · Korean Journal of Pediatrics · doi:10.3345/cep.2025.00822 · Cited by 2
“2 Likewise, adopted children encounter unique”
Phenomenology and Standard Care of OCD in Children and Adolescents
Greenberg, E., & GELLER, D. A. (2019) · Cambridge University Press eBooks · doi:10.1017/9781108235655.014 · Cited by 3
Self-citation
Metadata
- Authors
- Park, J. M., & Geller, D. A.
- Affiliations
- Massachusetts General Hospital (US)
- Harvard University (US)
- Corresponding author
- Geller, Daniel A.
- Venue
- F1000Prime Reports
- Publisher
- Faculty Opinions Ltd
- Published
- 2014-05-06
- Volume
- 6
- Pages
- 30-30
- ISSN
- 2051-7599 (ISSN-L)
- PMC
- PMC4017908
- OpenAlex
- W2001960276
- Cited by
- 2
- References
- 69
- Citations by year
- 2025: 1 · 2019: 1
- FWCI
- 0.00
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- F1000Prime Reports (publishedVersion)
- Europe PMC (PubMed Central) (publishedVersion, cc-by-nc)
- PubMed Central (publishedVersion, cc-by-nc)
- PubMed (publishedVersion)
- Digital Access to Scholarship at Harvard (DASH) (Harvard University) (submittedVersion, cc-by)
- Topics
- Social Sciences › Psychology › Experimental and Cognitive Psychology › Anxiety, Depression, Psychometrics, Treatment, Cognitive Processes
- Social Sciences › Psychology › Clinical Psychology › Child and Adolescent Psychosocial and Emotional Development
- Social Sciences › Psychology › Applied Psychology › Digital Mental Health Interventions
- Keywords
- childhood anxiety disorders, treatment-resistant anxiety, acceptance and commitment therapy, attentional bias modification, D-cycloserine, riluzole, glutamatergic agents, non-pharmacological treatment, pharmacotherapy
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
A language model drew the claims from the paper on 2026-10-11, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).
A second model labelled each claim on 2026-10-11 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.